Efficacy and safety of a salvage regimen based on tipranavir, enfuvirtide and three nucleoside analogues in HIV1 infected patients with clinical progression: 96-week evaluation.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples